Stay updated on Pembrolizumab Combo in Metastatic NSCLC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Combo in Metastatic NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Combo in Metastatic NSCLC Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Added related topics: Lung cancer and MedlinePlus Genetics to the page to link to broader information.
    Difference
    0.1%
    Check dated 2026-01-07T01:20:51.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    21 days ago
    Change Detected
    Summary
    The study's locations section was expanded to include new sites across multiple countries and states, and several prior location entries were removed. A revision tag (Revision: v3.3.3) is also noted on the page.
    Difference
    2%
    Check dated 2025-12-23T17:27:37.000Z thumbnail image
  4. Check
    28 days ago
    No Change Detected
  5. Check
    50 days ago
    Change Detected
    Summary
    Lung cancer and related topics (MedlinePlus Genetics) were added and the Publications note now states that publications are automatically filled from PubMed, with the revision tag updated from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T17:51:48.000Z thumbnail image
  6. Check
    57 days ago
    Change Detected
    Summary
    The government funding notice at the bottom of the page has been removed. The study details and overall content remain unchanged.
    Difference
    0.2%
    Check dated 2025-11-17T17:29:50.000Z thumbnail image
  7. Check
    64 days ago
    Change Detected
    Summary
    - The related topics section no longer lists Lung cancer and MedlinePlus Genetics. This is a minor navigational/metadata change that does not affect the study content.
    Difference
    0.1%
    Check dated 2025-11-10T14:45:57.000Z thumbnail image
  8. Check
    71 days ago
    Change Detected
    Summary
    No significant changes were detected in core study details; observed updates seem limited to formatting or UI adjustments. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-11-03T11:58:04.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Combo in Metastatic NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in Metastatic NSCLC Clinical Trial page.